Operations as a competitive advantage in biotechnology

McKinsey

Esteban Santos, executive vice president for operations at Amgen, explains how the company is using operations to support innovation. Insights on Pharmaceuticals & Medical Products

The new world of patient engagement

McKinsey

The CEO of Acorda Therapeutics, Ron Cohen, explains how the biotechnology company’s relationship with patients is changing and what that means. Our Insights

Profile of success: Theranos founder, Elizabeth Holmes

Consultants Mind

Theranos is a biotechnology start up merging biological systems with information systems. If you don’t know this company, clearly you are not paying attention. Home healthcare monitoring systems to monitor disease progression in real-time. Originally, it was catering to pharmaceutical trials … Continue reading → Learning Entrepreneur

Rolling Stones in Cuba: Glasnost

Consultants Mind

Biotechnology. A Brookings Institute report (somewhat dated 2013),says that the Cuban biotechnology industry is impressive and is comparable to one of the largest US biotechnology firms or a mid-sized international pharma company. Cuba Glasnost.

Do You Have the Right Decision Making Culture?

LSA Global

Examples of common fact-based decision making cultures include biotechnology, finance, and medical device companies. Decision Making Culture.

Weekend fun – read a good book: “Makers”

Killer Consultant

The story makes you learn about important innovation trends, like 3D printing, open innovation, crowdsourcing, biotechnology body enhancing, etc. I’ve been enjoying this book tremendously over the last days, thought I’d let you know about it.

Fourth Industrial Revolution: Robots, Artificial Intelligence Will Destroy 5.1 Million Jobs by 2020

MishTalk

The Fourth Industrial Revolution includes developments artificial intelligence, robotics, nanotechnology, 3-D printing, genetics, and biotechnology.

Top 10 Consulting Firms in San Francisco

Management Consulted

San Francisco, and the Bay Area in general, is famous for its long history of leadership in computing, semiconductors, software, biotechnology, the Internet and other innovation-based industries. C1 Consulting: A boutique life-sciences consulting firm committed to helping pharmaceutical and biotechnology clients.

Framework for Understanding Market Tops and Bottoms

MishTalk

One area that currently is frothy is the biotechnology sector. Last week I received an excellent article from Variant Perception on "Market Tops", and have permission to excerpt some of it. Here is a link to the summary page of Understanding Market Tops.

The Brattle Group Interviews and Culture

Management Consulted

In healthcare, the firm focuses on the enormous and fast-growing sectors of pharmaceuticals, medical devices, and biotechnology. THE BRATTLE GROUP. Today we take a look at a boutique consulting firm you may not have heard of, The Brattle Group. Founded in 1990, The Brattle Group offers answers to economic, regulatory and financial questions posed by corporations, law firms and governments around the globe.

Groups 100

Research: The Average Age of a Successful Startup Founder Is 45

Harvard Business

However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. Patricia de Melo Moreira/bloomberg/Getty Images. It’s widely believed that the most successful entrepreneurs are young. Bill Gates, Steve Jobs, and Mark Zuckerberg were in their early twenties when they launched what would become world-changing companies. Do these famous cases reflect a generalizable pattern? VC and media accounts seem to suggest so.

Innovation Should Be a Top Priority for Boards. So Why Isn’t It?

Harvard Business

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Jason Jaroslav Cook Creative/Getty Images.

The Promise and Challenge of Big Data for Pharma

Harvard Business

From our unique vantage points at Genentech , a leading biotechnology company with a major data science practice, and The Data Incubator , a data-science education company that places and trains data scientists , we have seen how the pharmaceuticals industry has leveraged big data for some potentially revolutionary advances and the challenges it has faced along the way.

The Reason Silicon Valley Beat Out Boston for VC Dominance

Harvard Business

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Despite the East Coast roots of technology entrepreneurship and venture capital (VC), by the 1990s Silicon Valley had gained a major advantage over the Cambridge-Boston area. In 1995 Silicon Valley’s share of all VC investments in the U.S.

In Memory of Spock: Live Long and Prosper; Is He or Isn't He? Fish Tomatoes, Hand Transplants, Sci-Fi vs. Reality

MishTalk

But the agency was officially mandated with promoting biotechnology and bent over backwards to push GMOs onto the market. One of my favorite characters in TV history was Star Trek''s "Spock". Yesterday, Leonard Nimoy, Spock of ‘Star Trek,’ Died at 83.

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Are corporate boards as polarized politically as the general population?

Why Women Feel More Stress at Work

Harvard Business

In one study, female and male MBA students were paired and asked to negotiate the purported purchase of a biotechnology plant. Everyone in today’s supercharged workplaces experiences stress.

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

Harvard Business

The rationale for this approach is highlighted when you compare, for example, the different approaches to M&A employed by a number of legacy pharmaceutical companies and by some relatively newer players in the biotechnology industry.

How to Get Yourself Invited to Important Meetings

Harvard Business

She was on the legal compliance team at a fast-growing biotechnology company. MINCHU/Getty Images. In a work culture with too many meetings, we often look for tactics to get out of meetings. But sometimes you need to get into a meeting, perhaps because the decisions made there will have implications for you or your team, or maybe because you feel you’ve been left out of important discussions.

Why It’s So Hard to Train Someone to Make an Ethical Decision

Harvard Business

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. One of the conundrums of ethical decision making is that many moral decisions that are quite straightforward — even easy — to resolve in a classroom or during training exercises seem far more difficult to successfully resolve when confronted during actual day-to-day decision making.

Why Boards Aren’t Dealing with Cyberthreats

Harvard Business

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., One of the greatest challenges facing boards today is the one directors feel least prepared for: cybersecurity. Yahoo’s disclosure in December of what could be the largest data breach in history was hardly an isolated incident. Indeed, the Guardian dubbed 2016 the “year of the hack,” and cyberthreats are increasingly common across all sectors.

Companies Can Address Talent Shortages by Partnering with Educators

Harvard Business

“Together, in response to industry demand, we’re creating a dedicated pipeline of skilled biomanufacturing professionals,” said Bruce Van Dyke, chair of Quincy’s Biotechnology and Good Manufacturing Practice program, in a recent interview with us. Bernhard Lang/Getty Images. Although it’s hard to pinpoint when skills shortages became the norm in the U.S.,

Innovative Companies Get Their Best Ideas from Academic Research — Here’s How They Do It

Harvard Business

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. has been an innovation superpower.

Teams Solve Problems Faster When They’re More Cognitively Diverse

Harvard Business

We worked with a startup biotechnology company. Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. Over recent decades the rightful endeavor to achieve a more representative workforce has had an impact. Of course, there is a ways to go, but progress has been made.

Why Mexico’s Economy Doesn’t Depend on the Next U.S. President

Harvard Business

Intense biotechnology research and development activities at some of the country’s universities (and their research farms) have raised the complexity and level of the industry’s outputs. The Mexican peso initially fell 13% in trading after Republican Donald Trump won the U.S. presidency in a surprise result over Democratic nominee Hillary Clinton. It was the biggest drop for the currency since an economic crisis in 1994.

The Growing Conflict-of-Interest Problem in the U.S. Congress

Harvard Business

million for stock in drug device companies in 2015 alone (the numbers are estimates, which is all that is legally required), but Peters is a three-time winner of the Biotechnology Innovation Organization legislator of the year award, the only lawmaker so honored, and is noted for leading opposition to the Innovation Act , legislation that pharmaceutical companies opposed because it imposed new restrictions on patent-infringement lawsuits.

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business

By the mid-1980’s, the American semiconductor industry seemed like it was doomed. Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports.